Skip to main content
The BMJ logoLink to The BMJ
. 1988 Aug 13;297(6646):434–435. doi: 10.1136/bmj.297.6646.434

Intra-arterial hepatic chemotherapy for liver malignancy.

S T Malik 1, P F Wrigley 1
PMCID: PMC1833854  PMID: 2971418

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIERMAN H. R., BYRON R. L., Jr, MILLER E. R., SHIMKIN M. B. Effects of intra-arterial administration of nitrogen mustard. Am J Med. 1950 Apr;8(4):535–535. doi: 10.1016/0002-9343(50)90263-4. [DOI] [PubMed] [Google Scholar]
  2. Bern M. M., McDermott W., Jr, Cady B., Oberfield R. A., Trey C., Clouse M. E., Tullis J. L., Parker L. M. Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report. Cancer. 1978 Aug;42(2):399–405. doi: 10.1002/1097-0142(197808)42:2<399::aid-cncr2820420204>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  3. Chen H. S., Gross J. F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep. 1980 Jan;64(1):31–40. [PubMed] [Google Scholar]
  4. Grage T. B., Vassilopoulos P. P., Shingleton W. W., Jubert A. V., Elias E. G., Aust J. B., Moss S. E. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery. 1979 Oct;86(4):550–555. [PubMed] [Google Scholar]
  5. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987 Oct;107(4):459–465. doi: 10.7326/0003-4819-107-4-459. [DOI] [PubMed] [Google Scholar]
  6. Konno T., Maeda H., Iwai K., Maki S., Tashiro S., Uchida M., Miyauchi Y. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer. 1984 Dec 1;54(11):2367–2374. doi: 10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  7. Lokich J., Ensminger W. Ambulatory pump infusion devices for hepatic artery infusion. Semin Oncol. 1983 Jun;10(2):183–190. [PubMed] [Google Scholar]
  8. Oberfield R. A. Intraarterial hepatic infusion chemotherapy in metastatic liver cancer. Semin Oncol. 1983 Jun;10(2):206–214. [PubMed] [Google Scholar]
  9. Ridge J. A., Bading J. R., Gelbard A. S., Benua R. S., Daly J. M. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer. 1987 May 1;59(9):1547–1553. doi: 10.1002/1097-0142(19870501)59:9<1547::aid-cncr2820590903>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  10. Sigurdson E. R., Ridge J. A., Kemeny N., Daly J. M. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol. 1987 Nov;5(11):1836–1840. doi: 10.1200/JCO.1987.5.11.1836. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES